Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICU NASDAQ:LNSR NASDAQ:NNOX NASDAQ:NYXH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$4.80+0.2%$3.85$2.07▼$12.50$19.15M-1.05107,694 shs66,857 shsLNSRLENSAR$5.76-1.0%$5.84$5.06▼$13.43$71.48M0.87114,116 shs32,869 shsNNOXNano-X Imaging$1.06+1.0%$1.61$0.73▼$5.69$73.07M1.243.89 million shs690,056 shsNYXHNyxoah$1.58-3.7%$2.20$1.26▼$8.59$63.57M1.61272,738 shs282,958 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical+0.21%-5.33%+61.07%+24.35%-14.29%LNSRLENSAR-1.03%-6.04%-1.03%-7.84%-55.35%NNOXNano-X Imaging+0.95%-14.52%-39.77%-59.07%-79.42%NYXHNyxoah-3.66%-5.95%+13.67%-53.25%-79.85%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$4.80+0.2%$3.85$2.07▼$12.50$19.15M-1.05107,694 shs66,857 shsLNSRLENSAR$5.76-1.0%$5.84$5.06▼$13.43$71.48M0.87114,116 shs32,869 shsNNOXNano-X Imaging$1.06+1.0%$1.61$0.73▼$5.69$73.07M1.243.89 million shs690,056 shsNYXHNyxoah$1.58-3.7%$2.20$1.26▼$8.59$63.57M1.61272,738 shs282,958 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical+0.21%-5.33%+61.07%+24.35%-14.29%LNSRLENSAR-1.03%-6.04%-1.03%-7.84%-55.35%NNOXNano-X Imaging+0.95%-14.52%-39.77%-59.07%-79.42%NYXHNyxoah-3.66%-5.95%+13.67%-53.25%-79.85%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICUSeaStar Medical 2.00Hold$8.0066.67% UpsideLNSRLENSAR 2.33Hold$10.0073.61% UpsideNNOXNano-X Imaging 2.67Moderate Buy$4.00277.36% UpsideNYXHNyxoah 2.25Hold$5.96277.37% UpsideCurrent Analyst Ratings BreakdownLatest ICU, NNOX, LNSR, and NYXH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2026NYXHNyxoah Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$2.857/8/2026NNOXNano-X Imaging Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/7/2026NNOXNano-X Imaging Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$5.00 ➝ $3.006/22/2026NNOXNano-X Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold6/17/2026NYXHNyxoah Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$5.00 ➝ $3.005/22/2026NYXHNyxoah Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/14/2026ICUSeaStar Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$6.00 ➝ $8.005/13/2026NYXHNyxoah Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$9.00 ➝ $7.005/12/2026NYXHNyxoah Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$8.00 ➝ $5.005/11/2026LNSRLENSAR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/11/2026NYXHNyxoah Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICUSeaStar Medical$1.23M15.61N/AN/A$2.75 per share1.75LNSRLENSAR$58.44M1.21N/AN/A($2.18) per share-2.64NNOXNano-X Imaging$13.02M5.67N/AN/A$2.01 per share0.53NYXHNyxoah$11.33M5.41N/AN/A$1.43 per share1.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICUSeaStar Medical-$12.15M-$4.80N/AN/AN/A-828.62%-146.29%-96.48%8/12/2026 (Estimated)LNSRLENSAR-$34.28M-$0.58N/AN/AN/A50.94%-183.19%42.26%8/6/2026 (Estimated)NNOXNano-X Imaging-$75.02M-$1.58N/AN/AN/A-716.44%-70.96%-62.26%7/20/2026 (Estimated)NYXHNyxoah-$101.92M-$2.48N/AN/AN/A-543.21%-163.73%-80.24%8/5/2026 (Estimated)Latest ICU, NNOX, LNSR, and NYXH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2026Q2 2026ICUSeaStar Medical-$0.97N/AN/AN/A$0.49 millionN/A8/11/2026N/ANNOXNano-X Imaging-$0.1633N/AN/AN/A$5.39 millionN/A8/6/2026Q2 2026LNSRLENSAR-$0.1650N/AN/AN/A$14.65 millionN/A8/5/2026Q2 2026NYXHNyxoah-$0.47N/AN/AN/A$8.64 millionN/A7/20/2026Q1 2026NNOXNano-X Imaging-$0.20N/AN/AN/A$4.54 millionN/A6/25/2026Q1 2026NNOXNano-X ImagingN/A-$0.16N/A-$0.20N/A$4.31 million5/13/2026Q1 2026ICUSeaStar Medical-$0.8250-$0.90-$0.0750-$0.90$0.44 million$0.50 million5/12/2026Q1 2026NYXHNyxoah-$0.54-$0.43+$0.11-$0.43$7.05 million$7.38 million5/8/2026Q1 2026LNSRLENSAR$0.1850$1.56+$1.3750N/A$13.40 million$13.43 million4/20/2026Q4 2025NNOXNano-X Imaging-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthICUSeaStar MedicalN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ANYXHNyxoahN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICUSeaStar MedicalN/A2.732.71LNSRLENSARN/A2.381.08NNOXNano-X ImagingN/A3.643.40NYXHNyxoah0.530.990.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICUSeaStar Medical1.69%LNSRLENSAR40.15%NNOXNano-X Imaging21.49%NYXHNyxoahN/AInsider OwnershipCompanyInsider OwnershipICUSeaStar Medical0.70%LNSRLENSAR65.80%NNOXNano-X ImagingN/ANYXHNyxoahN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICUSeaStar Medical24.00 million3.97 millionNot OptionableLNSRLENSAR11012.28 million4.20 millionOptionableNNOXNano-X Imaging19069.59 millionN/AOptionableNYXHNyxoah11038.76 millionN/ANot OptionableICU, NNOX, LNSR, and NYXH HeadlinesRecent News About These CompaniesShort Interest in Nyxoah SA (NASDAQ:NYXH) Drops By 63.9%July 13 at 4:39 AM | marketbeat.comNyxoah touts Genio US launch traction, reimbursement stability at investor dayJuly 11, 2026 | msn.comNyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor DayJuly 10, 2026 | marketbeat.comNyxoah SA (NYXH) Analyst/Investor Day TranscriptJuly 8, 2026 | seekingalpha.comNyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst CautionJuly 8, 2026 | finance.yahoo.comNyxoah reports Q2 2026 preliminary revenue of €7.7MJuly 7, 2026 | msn.comNyxoah Announces Preliminary Results for the Second Quarter of 2026July 7, 2026 | globenewswire.comInformation on the total number of voting rights and sharesJune 30, 2026 | globenewswire.comPublication relating to transparency notificationsJune 29, 2026 | globenewswire.comNyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital ConcernsJune 24, 2026 | finance.yahoo.comNyxoah to Host Investor Day in New York on July 8, 2026June 23, 2026 | globenewswire.comNyxoah (NYXH) Gets a Hold from Stifel NicolausJune 23, 2026 | theglobeandmail.comInvitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026June 19, 2026 | globenewswire.comInvitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026June 19, 2026 | globenewswire.comPublication relating to transparency notificationsJune 17, 2026 | globenewswire.comNyxoah Receives $15 Million from the European Investment BankJune 17, 2026 | globenewswire.comNyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical TechnologyJune 16, 2026 | finance.yahoo.comInformation on the total number of voting rights and sharesJune 10, 2026 | globenewswire.com$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial LaunchJune 10, 2026 | globenewswire.comNyxoah Announces Closing of Underwritten Public OfferingJune 10, 2026 | globenewswire.comWhat's going on with Nyxoah stock Tuesday?June 9, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026As Stablecoins Keep Growing, These 2 Stocks BenefitBy Nathan Reiff | June 28, 2026Is Lennar Finally Turning the Corner After Its Housing Slump?By Leo Miller | June 16, 2026Doug Casey Calls AI a Super Bubble, Bets on Energy, Gold Miners and GrainsBy Bridget Bennett | July 6, 2026ICU, NNOX, LNSR, and NYXH Company DescriptionsSeaStar Medical NASDAQ:ICU$4.80 +0.01 (+0.21%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$4.78 -0.02 (-0.42%) As of 07/14/2026 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.LENSAR NASDAQ:LNSR$5.76 -0.06 (-1.03%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$5.70 -0.06 (-1.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Nano-X Imaging NASDAQ:NNOX$1.06 +0.01 (+0.95%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$1.08 +0.02 (+1.51%) As of 07:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Nyxoah NASDAQ:NYXH$1.58 -0.06 (-3.66%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$1.61 +0.03 (+1.90%) As of 05:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet 3 Overlooked Energy ETFs Delivering Strong Returns and Income 3 Space Stocks That Could Outshine SpaceX After Its IPO 3 Energy Stocks Racing to Fix AI's Power Problem JPMorgan’s Q2 Strength Gives the Stock Rally New Support No Space For Panic: T-Mobile Shrugs Off The Starlink Threat Prepare for the Next Wave of Factory Automation With These 3 Standout Names Wedbush Pounds the Table—Buy Sandisk Before August 5 Earnings Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
